Background
==========

*Vibrio parahaemolyticus*is a halophilic, Gram-negative bacterium, first discovered in 1950 during a food poisoning outbreak in Osaka, Japan. *V. parahaemolyticus*is a seafood-borne pathogen, which is a major causative agent of gastroenteritis particularly in regions with high seafood consumption. In Taiwan, Japan, and South East Asian countries, *V. parahaemolyticus*causes over half of all food poisoning outbreaks of bacterial origin \[[@B1]\]. In recent years outbreaks of *V. parahaemolyticus*infection have increased in the United States; and *V. parahaemolyticus*infection is estimated to be responsible for 5000 illnesses per year \[[@B2]\]. *V. parahaemolyticus*infections that caused gastroenteritis up until 1996 were associated with many different serotypes, with a predominance of O4 serogroup strains among clinical samples in the United States \[[@B3]-[@B5]\]. In 1996 the first appearance of a pandemic *V. parahaemolyticus*clone occurred, a new O3:K6 serotype strain that has now been identified worldwide as a major cause of seafood-borne gastroenteritis \[[@B2]-[@B4],[@B6]-[@B9]\].

Clinical isolates of *V. parahaemolyticus*produce two major virulence factors; the thermostable direct hemolysin (TDH) encoded by *tdh*, and TDH-related hemolysin encoded by *trh*. Several studies have demonstrated that most pandemic *V. parahaemolyticus*new O3:K6 serotype isolates contain the *tdh*gene but not the *trh*gene and are hemolytic on Wagatsuma agar designated Kanagawa phenomenon positive strains (KP^+^) \[[@B2],[@B10],[@B11]\]. A number of additional biomarkers have been identified in pandemic *V. parahaemolyticus*serotype O3:K6 isolates; these include a unique *toxRS*sequence, a histone-like DNA-binding protein and an open reading frame VP2905, all found to be present exclusively in these strains \[[@B6],[@B12]-[@B14]\]. The recently emerged serotypes O4:K68, O1:KUT, O1:K25 and O1:K41 have been shown to be clonally related to new O3:K6 serotype strains isolated after 1995, all forming a pandemic group \[[@B3],[@B6],[@B14],[@B15]\]. It had been suggested that the new O3:K6 group strains might have emerged as a result of the transfer of genetic elements, and the *V. parahaemolyticus*phage f237 is believed to be responsible for the pandemic potential of *V. parahaemolyticus*\[[@B16]\]. However, many post-1995 *V. parahaemolyticus*isolates lack phage f237 \[[@B8],[@B17]\].

Genomic islands (GIs) are another group of chromosomal regions, which are acquired by horizontal gene transfer that may increase fitness of the bacterium in a particular environment. For example, virulence genes present on pathogenicity islands or genes that provide diverse metabolic capabilities on metabolic islands can play an important role in bacterial survival in diverse environments \[[@B18]\]. The DNA sequences of GIs are compositionally biased from their host genome in terms of G+C content, genome signature (dinucleotide frequency) and codon usage patterns \[[@B18]\]. As well as aberrant DNA composition, GIs have the general characteristics of encoding a bacteriophage-like integrase, are flanked by repeat sequences, and many GIs insert adjacent to tRNA genes probably indicating a similar mechanism of chromosomal integration. GIs are usually present in a subset of strains of a species and absent from closely related species. From the genomic sequence of *V. parahaemolyticus*RIMD2210633, an 81 kb region on chromosome 2 with a G+C content of 39% compared to the overall G+C content for the entire genome of 45% was identified \[[@B19]\]. This potential pathogenicity island encoded a type III secretion (TTS) system, which in other pathogenic bacteria export bacterial proteins directly into host cells. The TTS system on chromosome 2 was shown only to be present among *V. parahaemolyticus*isolates recovered after 1995 \[[@B19]\].

In the present study, we interrogated the complete genome sequence of *V. parahaemolyticus*strain RIMD2210633 an O3:K6 strain clinical isolate by bioinformatic and molecular analyses to identify GIs that may mark pandemic isolates. We uncovered 7 regions, ranging in size from 10 kb to 81 kb with the characteristics of GIs. We named these 7 regions *Vibrio parahaemolyticus*island-1 (VPaI-1) to VPaI-7. We examined the distribution of VPaI-1 among a collection of 41 *V. parahaemolyticus*natural isolates recovered between 1970 and 2003. By molecular analyses, the VPaI-1 region was only present amongst post-1995 serotype O3:K6 and related pandemic isolates indicating that this region may play a role in the emergence of pandemic isolates. In addition, we investigated the distribution of VPaI-4, VPaI-5, and VPaI-6 among the same collection of *V. parahaemolyticus*isolates and all 3 regions gave a similar distribution as VPaI-1 indicating that these regions, which encoded a number of potential virulence genes, may be involved in the emergence of pandemic isolates.

Results and discussion
======================

Genomic islands (GIs) identified in *V. parahaemolyticus*RIMD2210633
--------------------------------------------------------------------

We examined the whole genome sequence of *V. parahaemolyticus*RIMD2210633 to identify GIs that could potentially mark this pandemic clone. Initially we identified 9 regions of greater than 10 kb with aberrant G+C content that encoded integrase or transposase genes. These 9 regions included a prophage and an integron as well as 7 additional regions, which we named *V. parahaemolyticus*island-1 (VPaI-1) to VPaI-7. The 7 genomic islands (GIs) ranged in size from 10 kb to 81 kb, were flanked by direct repeats, and 6 of the 7 GIs had a G+C content lower (ranging from 38% to 43%) than the overall genome G+C content of 45% (Table [1](#T1){ref-type="table"}). All GIs encoded an integrase gene with the exception of VPaI-7, which contained a number of transposase genes. VPaI-7 is an 81 kb region that encoded a TTS system and the tdh gene and was previously identified as a potential pathogenicity island (Table [1](#T1){ref-type="table"}) \[[@B19]\]. Five GI regions were present on chromosome 1 and two on chromosome 2. Four of the GIs identified inserted adjacent to tRNA genes; VPaI-1 (tRNA-Met), VPaI-2 (tmRNA), VPaI-3 (tRNA-Ser) and VPaI-4 (tRNA-Ser) (Table [1](#T1){ref-type="table"}). Using the program developed by van Passel and co-workers, we examined the compositional dissimilarities among the 7 VPaI regions identified compared to the host genome (Table [1](#T1){ref-type="table"}) \[[@B20],[@B21]\]. A high genomic dissimilarity (δ\*) between a VPaI region and the *V. parahaemolyticus*genome sequence indicates a heterologous origin of the GI. All 7 VPaI regions that we examined had high δ\* values compared to the average for the genome of 38 for chromosome 1 and 36 for chromosome 2 (window size 10 kb) (Table [1](#T1){ref-type="table"}). In addition, we investigated the percent of genomic fragments of sizes equal to each VPaI with lower δ\* and between 94 and 100 percent of genomic fragments examined had a lower δ\* than the GI examined indicating that the 7 VPaI regions uncovered had an aberrant base composition compared to the rest of the genome (Table [1](#T1){ref-type="table"}).

Comparative analysis
--------------------

Each ORF present in the 7 VPaI regions was analysed systematically by BLAST analysis to determine whether these regions were present in sequenced members of the family *Vibrionaceae*; *V. vulnificus*strains YJ016 and CMCP6, *V. cholerae*N16961, and *V. fischeri*ES114. For all GIs, no homologues were present in these sequenced genomes. However, it was noted that four of the homologous insertion sites tRNA-Met, tmRNA, and two tRNA-Ser loci, did contain unique DNA in each of the four *Vibrio*genome sequences examined. At the tRNA-Met locus (genome location 403769--403844) in the *V. parahaemolyticus*RIMD2210633 sequence, we identified the 24 kb VPaI-1 region (Figure [1A](#F1){ref-type="fig"}). The VPaI-1 region encompassed ORFs VP0380 to VP0403 and encoded a phage-like integrase, type I restriction endonuclease, haemagglutinin associated protein, transmembrane protein, transcriptional regulators as well as a number of hypothetical proteins. Previously, we identified the homologous tRNA-Met locus as a hotspot for insertion of novel DNA in *V. vulnificus*and *V. cholerae*isolates \[[@B22]\]. At this site in both species a novel genomic island was inserted; in *V. vulnificus*YJ016, a 43 kb *V. vulnificus*island-I (VVI-I) was present and in *V. cholerae*O1 biotype El Tor pandemic strains, the 27 kb *Vibrio*seventh pandemic island-II (VSP-II) was present (Figure [1A](#F1){ref-type="fig"}) \[[@B22],[@B23]\]. In both *V. vulnificus*CMCP6 and *V. fischeri*ES114 the homologous tRNA-Met insertion site contained no novel DNA. In *V. vulnificus*CMCP6 the two homologous core chromosomal VPaI-1 flanking genes were adjacent to one another, whereas in *V. fischeri*ES114 only one flanking gene was identified (Figure [1A](#F1){ref-type="fig"}). At the tmRNA site (genome location 674355--675321) in *V. parahaemolyticus*RIMD2210633, the VPaI-2 region is present, which encompassed ORFs VP0635 to VP0643 and encoded an integrase, outer membrane protein, a resolvase, a ribonuclease H1 protein as well as a number of hypothetical proteins (Figure [1B](#F1){ref-type="fig"}). At the homologous tmRNA site in *V. vulnificus*YJ016 a 20 kb island region was present and in *V. vulnificus*strain CMCP6 a 37 kb region was present \[[@B24]\]. In *V. cholerae*, the 42 kb *Vibrio*Pathogenicity Island-1 (VPI-1) region, which encodes the toxin co-regulated pilus, was present \[[@B25]\]. In *V. fischeri*ES114 at the homologous tmRNA site a 28 kb region was present, which showed homology to prophage genes. At a tRNA-Ser site (genome location 1121082--1121169) in *V. parahaemolyticus*RIMD2210633 the 32 kb VPaI-3 region was present (Figure [2A](#F2){ref-type="fig"}). The VPaI-3 region encompasses ORFs VP1071 to VP1094 and encoded an integrase, a signal transduction histidine kinase, a helicase, a methyl accepting chemotaxis protein, an AcrBDF family protein as well as numerous hypothetical proteins. In *V. vulnificus*at the homologous insertion site, a 117 kb region was present and in CMCP6 a 29 kb region with homology to the 117 kb region in YJ016 was present (Figure [2A](#F2){ref-type="fig"}) \[[@B24]\]. At the homologous site in *V. cholerae*the 57 kb VPI-2 region, which encoded neuraminidase and genes required for sialic acid metabolism, was present \[[@B26],[@B27]\]. In *V. fischeri*ES114 at this site no horizontally acquired DNA was present (Figure [2A](#F2){ref-type="fig"}). In *V. parahaemolyticus*RIMD2210633, at a second tRNA-Ser site (genome location 2239837--2239927) the 17 kb VPaI-4 region was present encompassing ORFs VP2131 to VP2144 (Figure [2B](#F2){ref-type="fig"}). The VPaI-4 region encoded an integrase, a putative pore forming cytotoxin integrase, an M protein, an ATPase, a histone deacetylase as well as a number of hypothetical proteins. The M protein is a classical bacterial surface expressed virulence factor and the cytotoxin integrase may also be a potential virulence factor. At the homologous tRNA-Ser site in both *V. vulnificus*strains YJ016 and CMCP6 a 7.5 kb region of unique DNA was present (Figure [2B](#F2){ref-type="fig"}). However, at the homologous sites in *V. cholerae*N16961 and *V. fischeri*ES114 no novel DNA was present, and in *V. cholerae*the core flanking island genes were adjacent to one another (Figure [2B](#F2){ref-type="fig"}). The 12 kb VPaI-5 region encompassed ORFs VP2900 to VP2910 (Figure [3A](#F3){ref-type="fig"}). VPaI-5 encoded in addition to two integrases, a number of unknown and hypothetical proteins. The homologous core chromosomal flanking genes of VPaI-5 in *V. vulnificus*strains YJ016 and CMCP6, *V. cholerae*N16961 and *V. fischeri*ES114 were adjacent to one another indicating the absence of novel DNA at this site (Figure [3A](#F3){ref-type="fig"}). The 27 kb VPaI-6 region encompassed VPA1254 to VPA1270 and encoded an integrase, 3, 4 dihydroxy-2-butanone-4 phos (DHBP) synthase, two putative colicin proteins, a hydrolase and a number of hypothetical proteins. The homologous core chromosomal flanking genes of VPaI-6 in *V. vulnificus*strains YJ016 and CMCP6, *V. cholerae*N16961 and *V. fischeri*ES114 were either dispersed on the genome or were absent (Figure [3B](#F3){ref-type="fig"}). The 81 kb VPaI-7 region encompassed VPA1312 to VPA1398 encoded a TTS system previously described by Makino and colleagues \[[@B19]\].

Distribution of VPaI-1 among pre-1996 and post-1995 isolates
------------------------------------------------------------

Since the tRNA-Met site in *V. cholerae*isolates contained DNA (VSP-II) unique to pandemic isolates, we decided to examine this region further among *V. parahaemolyticus*isolates \[[@B23],[@B28]\]. To determine whether VPaI-1 is unique to pandemic *V. parahaemolyticus*, we examined a collection of 41 *V. parahaemolyticus*strains encompassing various serotypes recovered from a range of geographic regions over a 30 year period. The *V. parahaemolyticus*strains examined included 10 serotype O3:K6 isolates recovered between 1980 and 1995; 17 serotype O3:K6 isolates recovered between 1996 and 1998; 13 isolates representing serotypes O1:KUT, O1:K25 (2 isolates), O2:K28, O3:K4, O3:K53, O4:K8, O4:K11 (2 isolates), O4:K68 (3 isolates) and O8:K22, and 1 strain of undetermined serotype (Table [2](#T2){ref-type="table"}). These 41 isolates were further characterized using the differences in *toxRS*nucleotide sequence first described by Matsumoto and co-workers, which they called a group specific PCR (GS-PCR) that has been shown to differentiate post-1995 pandemic strains from non-pandemic and pre-1996 isolates (Table [2](#T2){ref-type="table"}) \[[@B6]\]. Of the 41 *V. parahaemolyticus*strains examined using GS-PCR, 25 strains gave a positive PCR band of the expected size and 16 *V. parahaemolyticus*isolates did not yield any PCR product (Table [2](#T2){ref-type="table"}). One *toxRS*-positive strain 1364 was previously shown by Wong and colleagues to belong to the old O3:K6 group and in their analysis this strain gave no PCR band with the same primer pair \[[@B15]\]. Our result suggests that the isolate we examined was not the same 1364 strain. We sequenced the housekeeping gene malate dehydrogenase (*mdh*) from strain 1364 using a primer pair designed from the sequenced strain RIMD2210633. The *mdh*nucleotide sequence from strain 1364 differed by only one nucleotide from the RIMD2210633 *mdh*sequence indicating they are very closely related strains. One additional strain gave anomalous results compared to a previous study, where KE10464 was shown by Osawa and colleagues to give positive PCR results with the *toxRS*primer pair \[[@B29]\]. It appears that there may have been a mix up in strain numbering in the distribution of these strains.

A total of 9 primer pairs were used to determine the distribution of VPaI-1 among 41 *V. parahaemolyticus*natural isolates (Table [3](#T3){ref-type="table"}). Six primer pairs were designed within the VPaI-1 region, two primer pairs encompassing each of the VPaI-1 flanking core chromosomal genes, VP0379 and VP0404, and a primer pair comprised of a forward primer from VP0379 and a reverse primer designed from VP0404 (Table [3](#T3){ref-type="table"}). Of the 41 *V. parahaemolyticus*strains examined by PCR with 6 primer pairs encompassing the VPaI-1 region (VP0380 to VP0403), 24 strains gave positive PCR bands of the expected sizes indicating the presence of VPaI-1 in these strains (Figure [4A](#F4){ref-type="fig"}, Table [4](#T4){ref-type="table"}). For example, PCR assays with primer pair VP0388F/VP0392R on DNA from the 41 *V. parahaemolyticus*isolates, gave an expected size product of 2.3 kb with 24 strains (Figure [4A](#F4){ref-type="fig"}, lanes 2 to 25). The 24 PCR positive strains were all recovered post-1995 and had a worldwide distribution (Table [4](#T4){ref-type="table"}); 17 *V. parahaemolyticus*serotype O3:K6 strains, 1 serotype O4:K11 strain recovered in Taiwan in 1999, 1 serotype O1:KUT recovered in Bangladesh and 2 serotype O1:K25 strains recovered in Taiwan and Thailand in 1998 and 1999, 3 serotype O4:K68 strains recovered in 1998 and 1999 in Bangladesh, Singapore and Taiwan (Table [4](#T4){ref-type="table"}). These VPaI-1 positive isolates were the same set of isolates that gave positive PCR products with the GS-PCR primer pair (Table [2](#T2){ref-type="table"}). All *V. parahaemolyticus*strains recovered pre-1996 gave negative PCR results for the six primer pairs encompassing VPaI-1 as well as five strains isolated in Spain and Taiwan between 1998 and 2003 (Table [4](#T4){ref-type="table"}). All PCR negative results were confirmed by Southern hybridisation analysis using DNA probes encompassing VP0388 to VP0392. Of the 17 VPaI-1 negative *V. parahaemolyticus*isolates, 16 were negative for the GS-PCR assay, the exception being strain KE10462 (Table [4](#T4){ref-type="table"}).

To determine whether in each of the VPaI-1-positve strains the chromosomal insertion site was identical, a primer pair was designed which comprised of a forward primer within VP0379, the 5\' core VPaI-1 flanking gene, and a reverse primer within VP0380, the first gene within the island. For all VPaI-1-positive isolates, a 2.3 kb PCR product was obtained (Figure [4A](#F4){ref-type="fig"}). To confirm that the VPaI-1 regions examined by PCR assays were contiguous within each isolate, overlapping PCR was carried out using three sets of primer pairs on VPaI-1-positive strains only (Table [3](#T3){ref-type="table"}). For example, a primer pair encompassing VP0384 to VP0387 was used to amplify a 3 kb product from all VPaI-1-positives isolates, indicating that this region is contiguous with VP0382-VP0384 amongst these isolates (Figure [4A](#F4){ref-type="fig"}).

As expected, positive PCR results with primer pairs marking 5\' VP0379 and 3\' VP0404 core chromosomal VPaI-1 flanking genes were obtained for all 41 *V. parahaemolyticus*strains, indicating that these genes are present in all isolates (Table [4](#T4){ref-type="table"}). Thus, primer pair VP0379F/VP0379R and VP0404F/VP0404R gave a 0.6 kb and 1.4 kb PCR product with all 41 strains tested (Figure [4A](#F4){ref-type="fig"}). To determine whether in VPaI-1-negative isolates these core chromosomal genes (VP0379 and VP0404) are adjacent to one another, we carried out a PCR assay with a forward primer (379F) designed from VP0379 and a reverse primer (404R) designed from VP0404 (Figure [4B](#F4){ref-type="fig"}). We found that among the 17 isolates that did not contain the VPaI-1 region, 15 strains gave a positive PCR band of 2.9 kb indicating that in these strains VP0379 and VP0404 are adjacent to one another and the insertion site for VPaI-1 is empty (Table [4](#T4){ref-type="table"}, Figure [4B](#F4){ref-type="fig"}). Two VPaI-1 negative strains, 428/00 and 30824 recovered in Spain 1998 and 1999, did not yield a PCR product with the primer pair 379F and 404R, which suggested that additional DNA may be present in these strains at this region (Figure [4B](#F4){ref-type="fig"}). We performed long range PCR on both of these isolates and obtained a 7 kb product indicating that in these isolates 4 kb of novel DNA is present (Figure [4C](#F4){ref-type="fig"}). Further analysis by Southern hybridisation using a DNA probe from the 379F/404R primer pair PCR product from strain KE9984 (VPaI-1 negative strain) showed the expected band sizes from strain 428/00 and 30824. Hybridisation of *Eco*R1 digested RIMD2210633 DNA with the 379/404 probe produced the expected size bands of 11.4 kb, 6.6 kb and 3 kb (Figure [5](#F5){ref-type="fig"}, lane 3). Hybridisation of *Eco*RI digested KE9984 and KE9967 DNA (VPaI-1 negative strains) with the 379/404 probe gave an expected 11.4 kb and 8 kb bands indicating that in these strains this tRNA-Met site is empty. Strains 30824 and 428/00 gave an approximately 11 kb and 13 kb size bands with the 379/404 DNA probe indicating that in these strains a 4 kb fragment of DNA is present between VP0379 and VP0404 (Figure [5](#F5){ref-type="fig"}).

Distribution of VPaI-4 among *V. parahaemolyticus*
--------------------------------------------------

To further examine the possible link between the acquisition of novel DNA and the emergence of pandemic isolates, we investigated the presence of three additional regions (VPaI-4, VPaI-5, and VPaI-6) among our collection of 41 *V. parahaemolyticus*isolates. For molecular analyses of VPaI-4, 7 primer pairs designed from strain RIMD2210633 encompassing the 17 kb region and the core 5\' and 3\' VPaI-4 core chromosomal flanking genes were used (Table [3](#T3){ref-type="table"}). The 4 internal VPaI-4 primer pairs gave PCR products of the expected size with DNA template from each of 24 of the 41 isolates examined (Table [5](#T5){ref-type="table"}). These were the same 24 isolates that were positive for the presence of VPaI-1 (Table [4](#T4){ref-type="table"}). For both the 5\' and 3\' core chromosomal VPaI-4 flanking primer pairs the expected size PCR products were obtained for all 41 isolates examined indicating that they represent core ancestral genes (Table [5](#T5){ref-type="table"}). A PCR assay based on a primer pair binding to chromosomal regions flanking the VPaI-4 region was used to determine whether in VPaI-4-negative strains the flanking genes are adjacent to one another. As expected only the 17 VPaI-4-negative *V. parahaemolyticus*isolates gave a 2.5 kb PCR product with the primer pair designed from the 5\' and 3\' flanking genes (Table [5](#T5){ref-type="table"}). No PCR products were obtained with VPaI-4 positive strains since the distance between the primer binding sites is too large (Table [5](#T5){ref-type="table"}). This result showed that in VpaI-4-negative isolates the core chromosomal VPaI-4 flanking genes are adjacent to one another.

To show that in each of the VPaI-4-positive strains that the chromosomal insertion site was identical, a primer pair was designed that comprised of a forward primer within VPaI-4 gene VP2143 and a reverse primer within the 3\' core chromosomal flanking gene VP2145 (Table [3](#T3){ref-type="table"}). For all VPaI-4-positive isolates, an expected 3.3 kb PCR product was obtained (Figure [6A](#F6){ref-type="fig"}). To confirm that the VPaI-4 regions examined by PCR assays were contiguous within each isolate, overlapping PCR was carried out using an additional three sets of primer pairs (Table [3](#T3){ref-type="table"}). A primer pair encompassing VP2135 to VP2137 was used to amplify a 2.9 kb product from all VPaI-4-positives isolates, indicating that this region is contiguous with VP2137-VP2139 (Figure [6A](#F6){ref-type="fig"}). Identical results were obtained with primer pairs encompassing VP2132 to VP2135 and VP2139 to VP2142 showing that these regions are contiguous. Thus it appears that in VPaI-4-positive isolates the structure and size of the island among the isolates is similar.

Distribution of VPaI-5 among *V. parahaemolyticus*
--------------------------------------------------

Three primer pairs encompassing the 12 kb VPaI-5 region were used to examine the 41 *V. parahaemolyticus*isolates (Table [3](#T3){ref-type="table"}). For all primer pairs, 24 isolates gave a PCR product of the expected size, these were the same 24 isolates that were positive for the presence of VPaI-1 and VPaI-4 (Table [6](#T6){ref-type="table"}). The 17 VPaI-5-negative isolates gave a 2.8 kb PCR product with a primer pair designed from the 5\' and 3\' core chromosomal VPaI-5 flanking genes VP2898 and VP2912 respectively, indicating that these genes are adjacent to one another and no novel DNA is present in these isolates (Table [6](#T6){ref-type="table"}).

By PCR assay we show that in each of the VPaI-5-positive strains the insertion site of the island was identical, with a forward primer within the 5\' core chromosomal flanking gene VP2898 and a reverse primer within the first gene of VPaI-5 VP2900 (Table [3](#T3){ref-type="table"}). From all VPaI-5-positive isolates an expected 4 kb PCR product was obtained indicating that the island is inserted at the same site in all strains tested (Figure [6B](#F6){ref-type="fig"}). To confirm that the VPaI-5 regions examined by PCR assays were contiguous within each isolate, overlapping PCR was carried out using an additional 3 sets of primer pairs (Table [3](#T3){ref-type="table"}). DNA from all VPaI-4-positives isolates by PCR assay amplified a 2.6 kb product with a primer pair encompassing VP2901 to VP2903 (Figure [6B](#F6){ref-type="fig"}). Identical results were obtained with primer pairs encompassing VP2903 to VP2905 and VP2906 to VP2908 with DNA from VPaI-5-positive isolates as template for PCR assays.

Distribution of VPaI-6 among *V. parahaemolyticus*
--------------------------------------------------

To determine the distribution of VPaI-6 (VPA1254 to VPA1270) encoded on chromosome 2, we used 6 primer pairs spanning the 27 kb region. Similar to the results for VPaI-1, VPaI-4, and VPaI-5, the same set of 24 isolates gave a PCR product of the expected size with each primer pair (Table [7](#T7){ref-type="table"}). A primer pair designed within VPA1251 and VPA1253, and a primer pair within VPA1271 all gave a positive PCR product with all strains examined indicating that these genes represent core chromosomal flanking genes (Table [7](#T7){ref-type="table"}). The 17 VPaI-6-negative strains gave an expected size PCR product of 0.8 kb with a primer pair designed from the 5\' and 3\' flanking genes (VPA1253 and VPA1271) indicating that these genes are adjacent to one another in these strains (Table [7](#T7){ref-type="table"}).

The insertion site of VPaI-6 among all isolates was examined by PCR assay with a forward primer within the 5\' core chromosomal flanking gene VPA1251 and a reverse primer within the first gene of VPaI-6, VPA1255 (Table [3](#T3){ref-type="table"}). For DNA from all VPaI-6-positive isolates an expected 4.6 kb PCR product was obtained indicating that the island is inserted at the same site in all strains tested (Figure [6C](#F6){ref-type="fig"}). To confirm that the VPaI-6 regions examined by PCR assays were contiguous within each isolate, overlapping PCR was carried out using additional sets of primer pairs (Table [3](#T3){ref-type="table"}). All VPaI-6-positive isolates by PCR assays, amplified a 4.6 kb PCR product with a primer pair encompassing VPA1251 to VPA1255, a 2 kb PCR product with primer pair VPA1256F/VPA1259R, a 1.4 kb product with a primer pair encompassing VPA1259 to VPA1261, and a 2.9 PCR product with VPA1264F/VPA1268R (Figure [6C](#F6){ref-type="fig"}). Similar to VPaI-1, VPaI-4 and VPaI-5, it appears that in VPaI-6-positive isolates, the island region has a similar structure and size among all the isolates examined.

Investigation of excision of VPaI-1, VPaI-4, VPaI-5 and VPaI-6
--------------------------------------------------------------

The integrase (*int*) genes of VPaI-1 and VPaI-4 exhibit homology to the *int*genes of coliphage P4 and bacteriophage phi CTX, respectively. The *int*genes of VPaI-5 and VPaI-6 show significant identities with other bacteriophages. In addition, VPaI-1, VPaI-4, VPaI-5 and VPaI-6 are flanked by direct repeats, which could be equivalent to the left and right attachment sites (*attL*and *attR*) that result from the integration of phage DNA. Therefore, it is possible that VPaI-1, VPaI-4, VPaI-5 and VPaI-6 may excise from the *V. parahaemolyticus*genome similar to *E. coli*PAIs, which have similar features, and form circular intermediates via site specific recombination between the direct repeats \[[@B30]\]. To determine the stability and potential mobility of VPaI-1, VPaI-4, VPaI-5, and VPaI-6, an inverse PCR assay was carried out to test for the presence of circular intermediates that result from excision of island regions (Figure [7](#F7){ref-type="fig"}). Total DNA was extracted from overnight cultures treated with and without mitomycin C (induces excision). PCR was carried out using a primer pair oriented towards the 5\' and 3\' island chromosomal flanking genes (Figure [7](#F7){ref-type="fig"}). A PCR product can only be amplified if the island regions have excised and formed circular intermediates with the primer binding sites oriented towards one another (Figure [7](#F7){ref-type="fig"}). Circular intermediates could not be detected under the conditions examined in this study for any of the 4 island regions tested. The deletion rate of these islands maybe very low and our PCR assay may not have been sensitive enough.

Conclusion
==========

In this study, we identified 7 regions named VPaI-1 to VPaI-7, which had all the features of genomic islands that is aberrant base composition compared to the entire genome, the presence of a phage-like integrase, insertion adjacent to tRNA genes and variable presence among strains. A number of the VPaI regions (VPaI-4 and VPaI-6) encoded putative virulence genes (M protein, hydrolases, cytotoxin integrase, colicins) and therefore these regions may represent potential pathogenicity islands. VPaI-1 encoded a type 1 restriction modification gene cluster, which could potentially be involved in protecting the bacterium from viral infections (Virus resistance island). However, all the VPaI regions encoded a large proportion of hypothetical and unknown proteins. We examined the 24 kb VPaI-1 region among a range of pandemic and non-pandemic *V. parahaemolyticus*isolates recovered over the past 33 years. We determined that VPaI-1 was unique to the pandemic group of *V. parahaemolyticus*strains isolated after 1995. Further analysis of 3 additional regions, VPaI-4, VPaI-5, and VPaI-6 showed that these too were unique to the pandemic clone, indicating that the acquisition of novel DNA by horizontal gene transfer has played an important role in the emergence of these strains. The 12 kb VPaI-5 region encompassing VP2900 to VP2910 encodes ORF VP2905, which was previously shown to be associated with the pandemic group of *V. parahaemolyticus*isolates \[[@B31]\]. The VPaI-5 region was previously noted by Okura and co-workers to encode a phage-like protein and may therefore encode a phage \[[@B14]\]. Previous studies examining the presence of strain specific DNA among pathogenic *V. cholerae*isolates have shown that the acquisition of DNA encoding virulence genes has played a crucial role in the emergence of pandemic isolates of this species \[[@B22],[@B25],[@B27],[@B28],[@B32]\]. The emergence of a novel epidemic *V. cholerae*O139 serogroup in 1992 was shown to have resulted from the horizontal transfer of the O139 gene cluster into an O1 serogroup strain as well as the acquisition of a capsule polysaccharide and an integrative conjugative element \[[@B33]-[@B37]\]. The insertion of 4 of our VPaI regions adjacent to tRNA genes has previously been described for a number of GIs in Gram-negative bacteria \[[@B38]-[@B40]\]. More recently it has been noted that there is a bias in the integration of GIs into specific tRNA loci \[[@B41],[@B42]\]. As the VPaI regions described in this study are examined further their role in the emergence of a pandemic clone will be elucidated. The recent discovery that *V. cholerae*isolates are naturally competent in the presence of chitin, an abundant substrate in the aquatic environment, may indicate a possible mechanism of DNA acquisition among the *Vibrionaceae*\[[@B43]\].

Methods
=======

Genome sequences
----------------

Complete nucleotide sequence and annotation was retrieved and downloaded from NCBI ftp site for *V. parahaemolyticus*RIMD2210633 (NC_004603, NC_004605) \[[@B19],[@B44]\].

Identification of genomic islands (GIs)
---------------------------------------

Several criteria were used in this study to identify GIs within the sequenced strain RIMD2210633. Firstly, the complete genome sequence of RIMD2210633 was examined for regions of sequence composition bias such as aberrant G+C percentage compared to the entire chromosome. Regions of greater than 10 kb with a G+C content that differed from the host genome were then examined for the presence of integrase and transposase genes. The regions encoding a prophage (VP1549 to VP1589) and a superintegron (VP1765 to VP1866) were not examined further. Seven candidate GI regions were analysed for compositional bias of dinucleotide frequency. The dinucleotide frequency analysis calculates the genomic dissimilarity values δ\* (the average dinucleotide relative abundance difference) between GI sequences and the *V. parahaemolyticus*RIMD2210633 genome sequence using a web based application, deltarho-web \[[@B20],[@B21],[@B45]\].

The dinucleotide frequency analysis shows that each genome has a typical dinucleotide frequency (called the genome signature ρ\*) and that related species have a similar genome signature \[[@B46],[@B47]\]. Van Passel\'s method also calculates the plot position (in %) of the GI sequence in the δ\*, compared to fragment number plot of the complete genome divided in non-overlapping fragments of equal size as the GI sequence, since the length of the GI sequence is important in calculating the relevance of the value of δ\* \[[@B20],[@B48]\]. Putative GI regions that fulfilled the criteria of aberrant G+C and dinucleotide frequency were then examined for the presence of insertion elements, flanking direct repeats, and proximity of tRNA. The 7 GI regions identified in *V. parahaemolyticus*strain RIMD2210633 by the above criteria were further analysed for sequence similarities using the BLAST algorithm to determine whether the ORFs present in each island are found among the other sequenced *Vibrio*genomes, *V. cholerae*N16961, *V. vulnificus*YJ016 and CMCP6, and *V. fischeri*ES114.

Bacterial strains
-----------------

A total of 41 *V. parahaemolyticus*isolates were used in this study (Table [2](#T2){ref-type="table"}). The source of the 41 *V. parahaemolyticus*isolates was temporally (1970 to 2003) and geographically (Asia, Europe and South America) widespread and encompassed 10 different serotypes (Table [2](#T2){ref-type="table"}). *V. parahaemolyticus*strains were grown in Luria-Bertani (LB) broth containing 3% NaCl. Stock cultures were stored at -80°C in LB broth containing 30% glycerol.

Molecular analysis
------------------

Of the 7 regions identified by bioinformatic analyses, we examined 4 regions in detail to determine their distribution among a collection of *V. parahaemolyticus*natural isolates. For polymerase chain reaction (PCR) assays, total DNA was extracted from overnight cultures in 3% NaCl LB broth using G-nome DNA isolation kit (Bio101, USA). To determine the presence of VPaI-1, for example, PCR assays using 6 primer pairs designed from ORFs VP0380 to VP0403 of the sequenced RIMD2210633 genome were used (Table [3](#T3){ref-type="table"}, Figure [4A](#F4){ref-type="fig"}). In addition, primer pairs VP379F/VP379R and VP404F/VP404R were designed to amplify the gene VP0379, which is immediately 5\' of VP0380 and the gene VP0404, which is immediately 3\' of the tRNA-Met gene, the insertion site of VPaI-1. To examine isolates that did not contain the VPaI-1 region, a single primer pair (379F/404R) consisting of a forward primer 379F and a reverse primer 404R was also used in this study to determine whether VP0379 and VP0404 are directly adjacent to one another in these VPaI-1 negative strains (Table [3](#T3){ref-type="table"}, Figure [4B](#F4){ref-type="fig"}). The 41 *V. parahaemolyticus*strains were also examined with the GS-PCR primer pair that specifically amplifies a 651 bp PCR product from new O3:K6 and related pandemic isolates \[[@B6],[@B12]-[@B14]\]. All PCR reactions were performed in volumes of 25 μl containing 40 ng DNA, 10 pmol primer and 1 U Taq polymerase with amplification conditions of 96°C for 3 min, followed by 30 cycles of 94°C for 30 sec, 45--60°C (depending on primer pair) for 30 sec and 72°C for 1--4 min (depending on expected PCR product size) and 72°C for 10 minutes. The sequenced *V. parahaemolyticus*strain RIMD2210633, which contains the VPaI-1 region was used as a positive PCR control. Long range PCR reactions were performed with Elongase ^®^Enzyme Mix (Invitrogen, Carlsbad, CA, USA). The thermal profile for the long-range PCR amplification included an initial pre-amplification denaturation cycle of 94°C for 30 s, followed by 33 cycles of 94°C for 30 s, 64°C for 30 s and 68°C for 20 minutes. The primer pairs used to investigate the presence of VPaI-4, VPaI-5 and VPaI-6 among the collection of *V. parahaemolyticus*isolates are listed in Table [3](#T3){ref-type="table"}. For all island-positive strains, overlapping PCR analysis was carried out with 3 to 4 additional PCR primer pairs per island to confirm that each island region was located at the same insertion site and that the structure of each island is similar amongst all the strains examined (Table [3](#T3){ref-type="table"}). Southern hybridisation analysis was performed on all VPaI-1 negative strains to confirm PCR negative results using a probe generated from the PCR product derived from primer pair VP0388F/VP0392 using reference strain RIMD2210633 as template. DNA from each VPaI-1 negative strain was digested with the restriction enzyme *Eco*RI (Roche Molecular Biochemicals) and the fragments were separated by electrophoresis in 0.6% TAE agarose. DNA fragments were transferred to nylon membrane by a posiblotter (Stratagene). Probe DNAs were labelled using the ECL direct nucleic acid labelling system (Amersham Pharmacia Biotech) and positive hybridization was detected by the ECL chemiluminescent substrate. Southern analyses were also preformed on VPaI-4, VPaI-5 and VPaI-6 negative strains using a probe generated from each of these island regions in RIMD2210633. Nucleotide sequence analysis of the *mdh*locus was preformed using a primer pair designed from VP0325.

Detection of excision of VPaI-1, VPaI-4, VPaI-5 and VPaI-6
----------------------------------------------------------

An inverse PCR assay was carried out to test for the presence of circular intermediates that result from excision of island regions. Five VPaI-positive and one VPaI-negative *V. parahemolyticus*strains were cultured in LB 3% NaCl broth. The broth was inoculated from single colonies taken from overnight plate cultures and incubated overnight on an orbital shaker at 30°C. The culture was induced to the lytic cycle by the addition of 40 ngml^-1^mitomycin C (Sigma-Aldrich). Induced cultures were further incubated for 8--10 h on an orbital shaker at 30°C. Cultures were centrifuged at 5000 g for 10 min to pellet bacterial cells and the supernatant fluids were filtered through 0·45μm membranes (Millipore). Aliquots of 2 μl were subsequently used as template for inverse PCR. Primer pairs oriented towards the 5\' and 3\' island chromosomal flanking genes were used to screen the filtrate (Table [3](#T3){ref-type="table"}). A PCR product can only be amplified if the island regions have excised and formed circular intermediates with the primer binding sites oriented towards one another.

Abbreviations
=============

TDH Thermostable Direct Hemolysin

GI Genomic Islands

TTS Type III Secretion

VPaI *V. parahaemolyticus*Island

tRNA Transfer RNA

ORFs Open Reading Frames

VVI-I *V. vulnificus*Island-I

GF Genomic Fragments

PAI Pathogenicity Island

PCR Polymerase Chain Reaction

GS-PCR Group Specific PCR
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![**A. Schematic representation of *V. parahaemolyticus*island-1 (VPaI-1) and the homologous tRNA-Met insertion site in *V. vulnificus*strains YJ016 and CMCP6, *V. cholerae*N16961, and *V. fischeri*ES114**. Block arrows represent annotated open reading frames (ORFs). Numbers above block arrows indicate ORF number on the sequenced genome strain. Black filled in ORFs represent core chromosomal genes. Open arrows represent genomic island ORFs. Shaded arrows represent integrase genes. Vertical arrows represent homologous tRNA-Met genes within each genome. Shaded blocks indicate homologous ORFs among the *Vibrio*species. B. Schematic representation of VPaI-2 from *V. parahaemolyticus*RIMD2210633.](1471-2164-7-104-1){#F1}

![**A and B. Schematic representation of *V. parahaemolyticus*island-3 (VPaI-3) and VPaI-4, and the homologous insertion site among the 4 sequenced *Vibrio*species**. Block arrows represent annotated ORFs. Black filled in ORFs represent core chromosomal flanking genes. Open and shaded arrows represent genomic island ORFs. Shaded blocks indicate homologous ORFs among the *Vibrio*species.](1471-2164-7-104-2){#F2}

![**A and B. Schematic representation of *V. parahaemolyticus*island-5 (VPaI-5) and VPAI-6, and the homologous insertion site among the 4 sequenced *Vibrio*species**. Block arrows represent annotated ORFs. Black filled in ORFs represent core chromosomal flanking genes. Open arrows represent genomic island ORFs. Shaded blocks indicate homologous ORFs among the *Vibrio*species.](1471-2164-7-104-3){#F3}

![**A. Schematic representation of VPaI-1 showing arrow heads representing primer pairs used in this study**. PCR analysis of the 41 *V. parahaemolyticus*strains is shown representing the results from 3 primer pairs. Lanes 1 and 44 represent size markers; lanes 2 to 42 contain strains analysed in the same order as in Table 2. For overlapping PCR primer pair analysis only VPaI-1-positive strains were examined, lanes 2 to 25 contain strains analysed in the same order as in Table 3. PCR primer pairs used are indicated under each agarose gel. B. Schematic representation of tRNA-Met site in VPaI-1-negative strains. Arrow heads represent primer pair used, which bind to the 5\' and 3\' core chromosomal flanking genes. PCR analysis of the 17 VPaI-1-negative isolates (lanes 26 to 42) from section A. The band size is marked on the left side of the PCR image. An expected 2.9 kb product was obtained for all strains except 428/00 and 30824 (Lanes 16 and 17). Lane 1 contains marker. C. Schematic representation of tRNA-Met site in VPaI-1 negative strains 428/00 and 30824. Arrow heads represent primer pair used. Long Template Expand PCR on strains 428/00 and 30824 showed 4 kb of DNA at this insertion site. The band size is marked on the left side of the PCR image.](1471-2164-7-104-4){#F4}

![**Southern hybridisation analysis of VPaI-1 negative strains 428/00 and 30824**. PaI-1-negative strains KE9984 and KE9967, VPaI-1-positive strain RIMD2210633 and VPaI-1-negative strains 30824 and 428/00. Genomic DNA was restricted using *Eco*RI and the probe used was constructed from the PCR amplification using primer pair 379F and 404R with strain KE9984 as template. The expected 8 Kb and 11.4 kb band sizes in the VPaI-1 negative strains KE9984 and KE9967 are shown (Lane 1--2). The VPaI-1 positive RIMD2210633 gave the expected 11.4 Kb, 6.6 Kb and 3.1 Kb band sizes (Lane 3). The VPaI-1 negative strains 30824 and 428/00 with novel DNA inserted gave the expected band sizes of 13 Kb and 11.4 Kb.](1471-2164-7-104-5){#F5}

![**Schematic representation of VPaI-4, VPaI-5 and VPaI-6 showing arrow heads representing overlapping and insertion site primer pairs used in this study (Table 3)**. Blue bars indicate regions tested for in all strains and red bars indicate regions tested for in VPaI-positive strains only. A. PCR analysis of the 24 VPaI-4-positive strains is shown. Lane 1 represents size marker; lanes 2 to 25 contain strains analysed in the same order as in Table 2. B. PCR analysis of the 24 VPaI-5-positive strains is shown. Lane 1 represents size marker; lanes 2 to 25 contain strains analysed in the same order as in Table 2. C. PCR analysis of the 24 VPaI-6-positive strains is shown. Lane 1 represents size marker; lanes 2 to 25 contain strains analysed in the same order as in Table 2.](1471-2164-7-104-6){#F6}

![**Schematic representation of chromosomally integrated and extrachromosomal excision product of hypothetical VPaI region**. Location of PCR primers used for analysis of excision products are shown as black arrows labelled PrimerR and PrimerF. Only formation of a circular intermediate or plasmid form of VPaI will allow for the amplification of a PCR product with primer pair primerF and primerR.](1471-2164-7-104-7){#F7}

###### 

Genomic Islands (Gis) identified in *V. parahaemolyticus*RIMD2210633 genome sequence.

  **GIs**   **Location (bp)(ORFs)**               **Directrepeat size**   **SizeKb**   **Int/Tnp**   **tRNAsite**   **%GC**   **1000X 6\***   **% GF withlower 6\***
  --------- ------------------------------------- ----------------------- ------------ ------------- -------------- --------- --------------- ------------------------
  VPaI-1    381054--403433 (VP0380--VP0403)       45                      24           Int           tRNA-Met       42        69.1            97.8
  VPaI-2    6660707--674355 (VP0635--VP0643)      10                      10           Int           tmRNA          45        76.7            93.9
  VPaI-3    1121252--1152668 (VP1071--VP1094)     \-                      32           Int           tRNA-Ser       42        53.1            98.8
  VPaI-4    2240007--2256166 (VP2131--VP2144)     30                      17           Int           tRNA-Ser       39        89.3            99.5
  VPaI-5    3084846--3099979 (VP2900--VP2910)     13                      12           Int           \-             38        130.5           100
  VPaI-6    1325821--1352643 (VPA1253--VPA1270)   8                       27           Int           \-             43        72.1            97.2
  VPaI-7    1390967--1501509 (VPA1312--VPA1398)   8                       81           Tnp           \-             39        77.4            100

δ\*-average dinucleotide relative abundance difference

Int/Tnp- Integrase/Transposase

GF-Genome Fragments

###### 

Bacterial strains used in this study.

  **Strain**    **Year Isolated**   **Serovar**   **Country of Isolation**   **Source**      **GS-PCR**   ***tdh***   **Reference**
  ------------- ------------------- ------------- -------------------------- --------------- ------------ ----------- ---------------
  RIMD2210633   1996                O3:K6         Japan                      Human           \+           \+          \[16\]
  97 LPV 2      1997                O3:K6         Laos                       Human           \+           \+          \[7\]
  VP2           1998                O3:K6         Korea                      Human           \+           \+          \[7\]
  VP47          1998                O3:K6         Thailand                   Human           \+           \+          \[7\]
  VP208         1997                O3:K6         India                      Human           \+           \+          \[15\]
  VP81          1996                O3:K6         India                      Human           \+           \+          \[7\]
  NIIDK7        1998                O3:K6         Japan                      Human           \+           \+          \[29\]
  KE10457       1998                O3:K6         Japan                      Human           \+           \+          \[29\]
  KE10472       1998                O3:K6         Japan                      Human           \+           \+          \[29\]
  KE10484       1998                O3:K6         Japan                      Human           \+           \+          \[29\]
  KE10495       1996                O3:K6         Japan                      Human           \+           \+          \[29\]
  KE10527       1998                O3:K6         Japan                      Food            \+           \+          \[29\]
  MW2           1998                O3:K6         Peru                       Human           \+           \+          This study
  MW3           1998                O3:K6         Peru                       Human           \+           \+          This study
  MW4           1998                O3:K6         Peru                       Human           \+           \+          This study
  MW5           1998                O3:K6         Peru                       Human           \+           \+          This study
  MW6           1998                O3:K6         Peru                       Human           \+           \+          This study
  A6            1999                O1:K25        Thailand                   Human           \+           \+          \[15\]
  1362          1999                O4:K68        Taiwan                     Human           \+           \+          \[15\]
  AN- 5034      1998                O4:K68        Bangladesh                 Human           \+           \+          \[7\]
  A18           1998                O4:K68        Singapore                  Human           \+           \+          \[15\]
  1364          1999                O4:K11        Taiwan                     Human           \+           \+          \[15\]
  AN-16000      1998                O1:KUT        Bangladesh                 Human           \+           \+          \[7\]
  1347          1998                O1:K25        Taiwan                     Human           \+           \+          \[15\]
                                                                                                                      
  UCM V586      2003                O8:K22        Spain                      Mollusc         \-           \-          \[7\]
  KE10443       1995                O3:K6         Japan                      Human           \-           \-          \[29\]
  KE10464       1988                O3:K6         Japan                      Food            \-           \-          \[29\]
  AQ4235        1987                O3:K6         Thailand                   Human           \-           \-          \[15\]
  AQ4299        1987                O3:K6         Thailand                   Human           \-           \-          \[15\]
  KE10462       1986                O3:K6         Japan                      Food            \+           \-          \[29\]
  AQ4037        1985                O3:K6         Maldives                   Human           \-           \-          \[15\]
  KE10461       1982                O3:K6         Japan                      Environmental   \-           \-          \[29\]
  KE9967        1981                O3:K6         Japan                      Human           \-           \+          \[29\]
  KE9984        1981                O3:K6         Japan                      Human           \-           \-          \[29\]
  U-5474        1980                O3:K6         Bangladesh                 Human           \-           \+          \[15\]
  ATCC43996     1970                O3:K4         U.K                        Human           \-           \+          \[7\]
  UCM V553      2003                O3:K53        Spain                      Mollusc         \-           \-          \[7\]
  UCM V493      2002                O2:K28        Spain                      Sediment        \-           \-          \[7\]
  30824         1999                O4:K11        Spain                      Human           \-           \+          \[7\]
  428/00        1998                N/A           Spain                      Human           \-           \+          \[7\]
  1324          1998                O4:K8         Taiwan                     Human           \-           \+          \[15\]

###### 

Primer Pairs used in this study.

  **Primers**                          **Anneal Temp**   **Product size**   **Primer sequences**
  ------------------------------------ ----------------- ------------------ -------------------------------------------------------------------------------
  **[VPaI-1]{.ul}**                                                         
  VP0379F-VP0379R                      52.2              589nt              Forward 5\'-CAGTAATCAAAGTCGGAGC -3\' Reverse 5\'-ATAACTGCGAGAGGTGC -3\'
  VP0380F-VP0380R                      50.7              1004nt             Forward 5\'-ATCTCTGGGATCAGTCAGG -3\' Reverse 5\'-GCGATAACGAGTCACTG -3\'
  VP0382F-VP0384R                      50.4              1809nt             Forward 5\'-CGTATTCCATGAATGTCGAG -3\' Reverse 5\'-GCTCTGCGTAATGCTTC -3\'
  VP0387F-VP0387R                      51.9              1422nt             Forward 5\'-CCTAGATTTCAAAGGAAGTGCG-3\' Reverse 5\'-GTCACGGATATGTTGTCTTG-3\'
  VP0388F-VP0392R                      53.4              2256nt             Forward 5\'-GTTGGTCTTAATGCCCG -3\' Reverse 5\'-ACGTACTGTTCAAGCCGAC -3\'
  VP0395F-VP0398R                      53.2              2393nt             Forward 5\'-TGTCCGCCAAAAACAGG -3\' Reverse 5\'-GCTGAGATCATCGAAAGTTACG -3\'
  VP0401F-VP0402R                      51                1171nt             Forward 5\'-GTCTTCTGTGAATGACTGC -3\' Reverse 5\'-TTAGCTTCTTCGTCACCCC -3\'
  VP0404F-VP0404R                      52.1              1397nt             Forward 5\'-CATGGGTATCAAGGTAGTAG -3\' Reverse 5\'-TCTCCATTGAGATTGGC -3\'
  379F-404R                            55.1              2842nt             Forward 5\'-ACCATAACTGCGAGAGGTGC -3\' Reverse 5\'-TGGTCGTACAACAGACCCAG -3\'
  **[Overlapping PCR Primers]{.ul}**                                        
  VP0379R-VP0380R                      50                2304nt             Forward 5\'-ATAACTGCGAGAGGTGC -3\' Reverse 5\'-GCGATAACGAGTCACTG -3\'
  VP0384R-VP0387R                      51                2990nt             Forward 5\'-CCGTAAGAGAAGAACGTG-3\' Reverse 5\'-CGAGTTAATGCAAAACTGGG-3\'
  VP0384R-VP0387R                      53                2035nt             Forward 5\'-ATTGGGGTTGGATGTCGTGG-3\' Reverse 5\'-CGAACGTGTTCAATACTACG-3\'
  **[VPaI-4]{.ul}**                                                         
  VP2130F-VP2130R                      52.3              1575nt             Forward 5\'-GCTTCGATGTTGATAGGC -3\' Reverse 5\'-GATGAGAGCAAGTTCTCG -3\'
  VP2131F-VP2133R                      51.3              1785nt             Forward 5\'-CACGTATTTCCACTCCAG -3\' Reverse 5\'-CCCATACTTCACCATCTTTC -3\'
  VP2135F-VP2135R                      50.4              1653nt             Forward 5\'-GGTAAGAGTGAAGAGGTTCAG-3\' Reverse 5\'-CCGACTGTAAATCTCATCG-3\'
  VP2137F-VP2139R                      50.9              2914nt             Forward 5\'-TCGTGTGAAATGCGAAC -3\' Reverse 5\'-CGACGTAGACTTTTAGCC -3\'
  VP2143F-VP2143R                      50.5              1354nt             Forward 5\'-GCAGTCGAACTTGAAGAC -3\' Reverse 5\'-ATGACCTCTCTGCATCC -3\'
  VP2145F-VP2145R                      52                727nt              Forward 3\'-TATCCACCACCCACAAC-3\' Reverse 3\'-ATGTGCAAGCTGAGTGG-3\'
  2130F- 2145R                         53.2              2851nt             Forward 5\'-GCTTCGATGTTGATAGGC -3\' Reverse 5\'-ATGTGCAAGCTGAGTGGGTG -3\'
  **[Overlapping PCR primers]{.ul}**                                        
  VP2143F-VP2145R                      49                3291nt             Forward 5\'-GCAGTCGAACTTGAAGAC -3\' Reverse 3\'-ATGTGCAAGCTGAGTGG-3\'
  VP2132F-VP2135R                      50                2387nt             Forward 5\'-TCCCTCGTTTCTTGCTC-3\' Reverse5\'-CTTGTCACAATGATCTCCTG-3\'
  VP2135F-VP2137R                      51                2900nt             Forward 5\'-GCTGGATTAGGACTTGATAC-3\' Reverse5\'-TACTAACCTCCCATCGG-3\'
  VP2140F-VP2142R                      52                2562nt             Forward 5\'-GGCGTAATTTCTCAGATTCC-3\' Reverse 5\'-GCTAAACGTGTTGCTGTTG-3\'
  **[VPaI-5]{.ul}**                                                         
  VP2900F-VP2900R                      50.3              1377nt             Forward 5\'-GGGGAACCAGTTATAGG-3\' Reverse 5\'-ACCGTGAGACGCAGTATCAG -3\'
  VP2905F-VP2905R                      50.7              2035nt             Forward 5\'-CTGATGAGCAGTTTCCG -3\' Reverse 5\'-TCCATTGTTGTTGCAGG -3\'
  VP2908F-VP2908R                      50.6              2313nt             Forward 5\'-GGCATGAAATCTTGCAG-3\' Reverse 5\'-CTCACATAGTTACATTGCGG
  2898F-2912R                          59.3              2800nt             Forward 5\'-CAGCCAAGACCACAAAC-3\' Reverse 5\'-AATCCCTAGCAGGTTGC-3\'
  **[Overlapping PCR primers]{.ul}**                                        
  VP2898F-VP2900R                      52                3988nt             Forward 5\'-CAGCCAAGACCACAAAC-3\' Reverse 5\'-ACCGTGAGACGCAGTATCAG -3\'
  VP2901F-VP2903R                      52                2577nt             Forward 5\'-AACGCCAAAGTTGCCTG -3\' Reverse 5\'-CCGTAAGTAAAGGTTCATCTGC -3\'
  VP2903F-VP2905R                      53                2330nt             Forward 5\'-TCACGTTTGAAGCTCGC -3\' Reverse 5\'-GTGCCGTATTCTCTTTGTAG -3\'
  VP2906F-VP2908R                      51.2              2197nt             Forward 5\'-GCCCATACAAGTATTCACTC -3\' Reverse 5\'-TAACCCACAACGATCCG -3\'
  **[VPaI-6]{.ul}**                                                         
  VPA1251F-VPA1253R                    51.3              1169nt             Forward 5\'-TCGTAAACACTGCCAGC -3\' Reverse 5\'-CTAGCAACGGTGATAGC -3\'
  VPA1255F-VPA1255R                    51.1              2098nt             Forward 5\'-GATGGTTGTGATGAGTTTGC -3\' Reverse 5\'-TGATGAAGCGATATGCC -3\'
  VPA1260F-VPA1261R                    51.5              2033nt             Forward 5\'-GGCTTTAGGTACTGCTACC -3\' Reverse 5\'-GGAATCACGTTCTCTGG -3\'
  VPA1262F-VPA1262R                    54.1              1851nt             Forward 5\'-GTGACTTCGAGTTCATTTGC -3\' Reverse 5\'-GCAACAGTGCATCAATTTGCTC -3\'
  VPA1263F-VPA1263R                    53                2144nt             Forward 5\'-CTACGAAGGTAATCTCGC -3\' Reverse 5\'-TACCCGCATCAGCTAAC -3\'
  VPA1266F-VPA1266R                    52.5              1879nt             Forward 5\'-ATCCCTTATCGCTCGAC-3\' Reverse 5\'-CGGATTGTGTTATCTCG-3\'
  VPA1270F-VPA1270R                    53.2              2225nt             Forward 5\'-TGGAACACGCATCCTAC-3\' Reverse 5\'-ACGACTGAGTTGCATCGAG-3\'
  VPA1271F-VPA1271R                    51.9              432nt              Forward 5\'-CAGCACACTTTTACTGGC -3\' Reverse 5\'-TGCATCGAACTAACCGC -3\'
  1253F-1271R                          53                782nt              Forward 5\'-ACTTCTGGCTGCGTTTC -3\' Reverse 5\'-CACTTTTACTGGCTTTCAGC -3\'
  **[Overlapping PCR primers]{.ul}**                                        
  VPA1251F-VPA1255R                    48                4590nt             Forward 5\'-TCGTAAACACTGCCAGC -3\' Reverse 5\'-TGATGAAGCGATATGCC -3\'
  VPA1256F-VPA1259R                    50.7              1995nt             Forward 5\'-GCCGAGTCAATAAATGTTGCAC -3\' Reverse 5\'-TTCTAGTTGAACGACGC -3\'
  VPA1259F-VPA1261R                    52.2              1367nt             Forward 5\'-AACGTCAATTTCTGGGG -3\' Reverse 5\'-GCATCTGAGACAAAGACTAAGG -3\'
  VPA1264F-VPA1268R                    53                2885nt             Forward 5\'-CGAACCTTAAATGGACG -3\' Reverse 5\'-GACTAATGGCAAGTGGG -3\'
  **[Inverse PCR primers]{.ul}**                                            
  VP0401F-VP0380R                      49                4596nt             Forward 5\'-GTCTTCTGTGAATGACTGC -3\' Reverse 5\'-GCGATAACGAGTCACTG -3\'
  VP2143F-VP2133R                      51                4614nt             Forward 5\'-GCAGTCGAACTTGAAGAC -3\' Reverse 5\'-CCCATACTTCACCATCTTTC -3\'
  VP2910F- VP2900R                     56                2939nt             Forward 5\'-CAACATGTACCCAGAGTACG -3\' Reverse 5\'-ACCGTGAGACGCAGTATCAG -3\'
  VPA1270F-VPA1255R                    48                4462nt             Forward 5\'-TGGAACACGCATCCTAC-3\' Reverse 5\'-GCTGGTGACCTCGATAC-3\'
  **[Genotypic primer pairs]{.ul}**                                         
  GS-VP.1 F-GS-VP.2 R                  45                651nt              Forward 5\'-TAATGAGGTAGAAACA-3\' Reverse 5\'-ACGTAACGGGCCTACA-3\'
  VP0325F-VP0325R                      54                901nt              Forward 5\'-TGAAAGTAGCCGTTATTGG -3\' Reverse 5\'-CCATTTAGCGTTTCTAGCATTC-3\'

###### 

Occurrence and distribution of Group Specific and VPaI-1 genesamong *V. parahaemolyticus*isolates.

  **Strains**    **Serovar**   **GS-PCR**   **VP 0379**   **VP 0380**   **VP 0382--84**   **VP 0387**   **VP 0388--92**   **VP 0395--98**   **VP 0401--02**   **VP 0404**   **379F-404R**
  -------------- ------------- ------------ ------------- ------------- ----------------- ------------- ----------------- ----------------- ----------------- ------------- ---------------
  RIMD 2210633   O3:K6         \+           \+            \+            \+                \+            \+                \+                \+                \+            \-
  97 LPV 2       O3:K6         \+           \+            \+            \+                \+            \+                \+                \+                \+            \-
  VP2            O3:K6         \+           \+            \+            \+                \+            \+                \+                \+                \+            \-
  VP47           O3:K6         \+           \+            \+            \+                \+            \+                \+                \+                \+            \-
  VP208          O3:K6         \+           \+            \+            \+                \+            \+                \+                \+                \+            \-
  VP81           O3:K6         \+           \+            \+            \+                \+            \+                \+                \+                \+            \-
  NIIDK7         O3:K6         \+           \+            \+            \+                \+            \+                \+                \+                \+            \-
  KE10457        O3:K6         \+           \+            \+            \+                \+            \+                \+                \+                \+            \-
  KE10472        O3:K6         \+           \+            \+            \+                \+            \+                \+                \+                \+            \-
  KE10484        O3:K6         \+           \+            \+            \+                \+            \+                \+                \+                \+            \-
  KE10495        O3:K6         \+           \+            \+            \+                \+            \+                \+                \+                \+            \-
  KE10527        O3:K6         \+           \+            \+            \+                \+            \+                \+                \+                \+            \-
  MW2            O3:K6         \+           \+            \+            \+                \+            \+                \+                \+                \+            \-
  MW3            O3:K6         \+           \+            \+            \+                \+            \+                \+                \+                \+            \-
  MW4            O3:K6         \+           \+            \+            \+                \+            \+                \+                \+                \+            \-
  MW5            O3:K6         \+           \+            \+            \+                \+            \+                \+                \+                \+            \-
  MW6            O3:K6         \+           \+            \+            \+                \+            \+                \+                \+                \+            \-
  A6             O1:K25        \+           \+            \+            \+                \+            \+                \+                \+                \+            \-
  1362           O4:K68        \+           \+            \+            \+                \+            \+                \+                \+                \+            \-
  AN-5034        O4:K68        \+           \+            \+            \+                \+            \+                \+                \+                \+            \-
  A18            O4:K68        \+           \+            \+            \+                \+            \+                \+                \+                \+            \-
  1364           O4:K11        \+           \+            \+            \+                \+            \+                \+                \+                \+            \-
  AN-16000       O1:KUT        \+           \+            \+            \+                \+            \+                \+                \+                \+            \-
  1347           O1:K25        \+           \+            \+            \+                \+            \+                \+                \+                \+            \-
                                                                                                                                                                            
  UCM V586       O8:K22        \-           \+            \-            \-                \-            \-                \-                \-                \+            \+
  KE10443        O3:K6         \-           \+            \-            \-                \-            \-                \-                \-                \+            \+
  KE10464        O3:K6         \-           \+            \-            \-                \-            \-                \-                \-                \+            \+
  AQ4235         O3:K6         \-           \+            \-            \-                \-            \-                \-                \-                \+            \+
  AQ4299         O3:K6         \-           \+            \-            \-                \-            \-                \-                \-                \+            \+
  KE10462        O3:K6         \+           \+            \-            \-                \-            \-                \-                \-                \+            \+
  AQ4037         O3:K6         \-           \+            \-            \-                \-            \-                \-                \-                \+            \+
  KE10461        O3:K6         \-           \+            \-            \-                \-            \-                \-                \-                \+            \+
  KE9967         O3:K6         \-           \+            \-            \-                \-            \-                \-                \-                \+            \+
  KE9984         O3:K6         \-           \+            \-            \-                \-            \-                \-                \-                \+            \+
  U-5474         O3:K6         \-           \+            \-            \-                \-            \-                \-                \-                \+            \+
  ATCC43996      O3:K4         \-           \+            \-            \-                \-            \-                \-                \-                \+            \+
  UCM V553       O3:K53        \-           \+            \-            \-                \-            \-                \-                \-                \+            \+
  UCM V495       O2:K28        \-           \+            \-            \-                \-            \-                \-                \-                \+            \+
  30824          O4:K11        \-           \+            \-            \-                \-            \-                \-                \-                \+            \-
  428/00         N/A           \-           \+            \-            \-                \-            \-                \-                \-                \+            \-
  1324           O4:K8         \-           \+            \-            \-                \-            \-                \-                \-                \+            \+

###### 

Distribution of VPaI-4 region (ORFs VP2131 to VP2144) among *V. parahaemolyticus*natural isolates.

  **Strain**     **Serovar**   **VP2130**   **VP2131--33**   **VP2135**   **VP2137--39**   **VP2143**   **VP2145**   **2130--2145**
  -------------- ------------- ------------ ---------------- ------------ ---------------- ------------ ------------ ----------------
  RIMD 2210633   O3:K6         \+           \+               \+           \+               \+           \+           \-
  97 LPV 2       O3:K6         \+           \+               \+           \+               \+           \+           \-
  VP2            O3:K6         \+           \+               \+           \+               \+           \+           \-
  VP47           O3:K6         \+           \+               \+           \+               \+           \+           \-
  VP208          O3:K6         \+           \+               \+           \+               \+           \+           \-
  VP81           O3:K6         \+           \+               \+           \+               \+           \+           \-
  NIIDK7         O3:K6         \+           \+               \+           \+               \+           \+           \-
  KE10457        O3:K6         \+           \+               \+           \+               \+           \+           \-
  KE10472        O3:K6         \+           \+               \+           \+               \+           \+           \-
  KE10484        O3:K6         \+           \+               \+           \+               \+           \+           \-
  KE10495        O3:K6         \+           \+               \+           \+               \+           \+           \-
  KE10527        O3:K6         \+           \+               \+           \+               \+           \+           \-
  MW2            O3:K6         \+           \+               \+           \+               \+           \+           \-
  MW3            O3:K6         \+           \+               \+           \+               \+           \+           \-
  MW4            O3:K6         \+           \+               \+           \+               \+           \+           \-
  MW5            O3:K6         \+           \+               \+           \+               \+           \+           \-
  MW6            O3:K6         \+           \+               \+           \+               \+           \+           \-
  A6             O1:K25        \+           \+               \+           \+               \+           \+           \-
  1362           O4:K68        \+           \+               \+           \+               \+           \+           \-
  AN-5034        O4:K68        \+           \+               \+           \+               \+           \+           \-
  A18            O4:K68        \+           \+               \+           \+               \+           \+           \-
  1364           O4:K11        \+           \+               \+           \+               \+           \+           \-
  AN-16000       O1:KUT        \+           \+               \+           \+               \+           \+           \-
  1347           O1:K25        \+           \+               \+           \+               \+           \+           \-
                                                                                                                     
  UCM V586       O8:K22        \+           \-               \-           \-               \-           \+           \+
  KE10443        O3:K6         \+           \-               \-           \-               \-           \+           \+
  KE10464        O3:K6         \+           \-               \-           \-               \-           \+           \+
  AQ4235         O3:K6         \+           \-               \-           \-               \-           \+           \+
  AQ4299         O3:K6         \+           \-               \-           \-               \-           \+           \+
  KE10462        O3:K6         \+           \-               \-           \-               \-           \+           \-
  AQ4037         O3:K6         \+           \-               \-           \-               \-           \+           \+
  KE10461        O3:K6         \+           \-               \-           \-               \-           \+           \+
  KE9967         O3:K6         \+           \-               \-           \-               \-           \+           \+
  KE9984         O3:K6         \+           \-               \-           \-               \-           \+           \+
  U-5474         O3:K6         \+           \-               \-           \-               \-           \+           \+
  ATCC43996      O3:K4         \+           \-               \-           \-               \-           \+           \+
  UCM V553       O3:K53        \+           \-               \-           \-               \-           \+           \+
  UCM V493       O2:K28        \+           \-               \-           \-               \-           \+           \+
  30824          O4:K11        \+           \-               \-           \-               \-           \+           \+
  428/00         N/A           \+           \-               \-           \-               \-           \+           \+
  1324           O4:K8         \+           \-               \-           \-               \-           \+           \+

###### 

Distribution of VPaI-5 region (ORFs VP2900 to VP2910) among *V. parahaemolyticus*natural isolates.

  **Strain**     **Serovar**   **VP 2901**   **VP 2905**   **VP 2908**   **2898--2912**
  -------------- ------------- ------------- ------------- ------------- ----------------
  RIMD 2210633   O3:K6         \+            \+            \+            \-
  97 LPV 2       O3:K6         \+            \+            \+            \-
  VP2            O3:K6         \+            \+            \+            \-
  VP47           O3:K6         \+            \+            \+            \-
  VP208          O3:K6         \+            \+            \+            \-
  VP81           O3:K6         \+            \+            \+            \-
  NIIDK7         O3:K6         \+            \+            \+            \-
  KE10457        O3:K6         \+            \+            \+            \-
  KE10472        O3:K6         \+            \+            \+            \-
  KE10484        O3:K6         \+            \+            \+            \-
  KE10495        O3:K6         \+            \+            \+            \-
  KE10527        O3:K6         \+            \+            \+            \-
  MW2            O3:K6         \+            \+            \+            \-
  MW3            O3:K6         \+            \+            \+            \-
  MW4            O3:K6         \+            \+            \+            \-
  MW5            O3:K6         \+            \+            \+            \-
  MW6            O3:K6         \+            \+            \+            \-
  A6             O1:K25        \+            \+            \+            \-
  1362           O4:K68        \+            \+            \+            \-
  AN-5034        O4:K68        \+            \+            \+            \-
  A18            O4:K68        \+            \+            \+            \-
  1364           O4:K11        \+            \+            \+            \-
  AN-16000       O1:KUT        \+            \+            \+            \-
  1347           O1:K25        \+            \+            \+            \-
                                                                         
  UCM V586       O8:K22        \-            \-            \-            \+
  KE10443        O3:K6         \-            \-            \-            \+
  KE10464        O3:K6         \-            \-            \-            \+
  AQ4235         O3:K6         \-            \-            \-            \+
  AQ4299         O3:K6         \-            \-            \-            \+
  KE10462        O3:K6         \-            \-            \-            \+
  AQ4037         O3:K6         \-            \-            \-            \+
  KE10461        O3:K6         \-            \-            \-            \+
  KE9967         O3:K6         \-            \-            \-            \+
  KE9984         O3:K6         \-            \-            \-            \+
  U-5474         O3:K6         \-            \-            \-            \+
  ATCC43996      O3:K4         \-            \-            \-            \+
  UCM V553       O3:K53        \-            \-            \-            \+
  UCM V493       O2:K28        \-            \-            \-            \+
  30824          O4:K11        \-            \-            \-            \+
  428/00         N/A           \-            \-            \-            \+
  1324           O4:K8         \-            \-            \-            \+

###### 

Distribution of VPaI-6 region (ORFs VPA1254 to VPA1270) among *V. parahaemolyticus*natural isolates.

  **Strain**     **Serovar**   **VPA1251--53**   **VPA1255**   **VPA1260**   **VPA1262**   **VPA1263**   **VPA1266**   **VPA1270**   **VPA1271**   **1253--1271**
  -------------- ------------- ----------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- ----------------
  RIMD 2210633   O3:K6         \+                \+            \+            \+            \+            \+            \+            \+            \-
  97 LPV 2       O3:K6         \+                \+            \+            \+            \+            \+            \+            \+            \-
  VP2            O3:K6         \+                \+            \+            \+            \+            \+            \+            \+            \-
  VP47           O3:K6         \+                \+            \+            \+            \+            \+            \+            \+            \-
  VP208          O3:K6         \+                \+            \+            \+            \+            \+            \+            \+            \-
  VP81           O3:K6         \+                \+            \+            \+            \+            \+            \+            \+            \-
  NIIDK7         O3:K6         \+                \+            \+            \+            \+            \+            \+            \+            \-
  KE10457        O3:K6         \+                \+            \+            \+            \+            \+            \+            \+            \-
  KE10472        O3:K6         \+                \+            \+            \+            \+            \+            \+            \+            \-
  KE10484        O3:K6         \+                \+            \+            \+            \+            \+            \+            \+            \-
  KE10495        O3:K6         \+                \+            \+            \+            \+            \+            \+            \+            \-
  KE10527        O3:K6         \+                \+            \+            \+            \+            \+            \+            \+            \-
  MW2            O3:K6         \+                \+            \+            \+            \+            \+            \+            \+            \-
  MW3            O3:K6         \+                \+            \+            \+            \+            \+            \+            \+            \-
  MW4            O3:K6         \+                \+            \+            \+            \+            \+            \+            \+            \-
  MW5            O3:K6         \+                \+            \+            \+            \+            \+            \+            \+            \-
  MW6            O3:K6         \+                \+            \+            \+            \+            \+            \+            \+            \-
  A6             O1:K25        \+                \+            \+            \+            \+            \+            \+            \+            \-
  1362           O4:K68        \+                \+            \+            \+            \+            \+            \+            \+            \-
  AN-5034        O4:K68        \+                \+            \+            \+            \+            \+            \+            \+            \-
  A18            O4:K68        \+                \+            \+            \+            \+            \+            \+            \+            \-
  1364           O4:K11        \+                \+            \+            \+            \+            \+            \+            \+            \-
  AN-16000       O1:KUT        \+                \+            \+            \+            \+            \+            \+            \+            \-
  1347           O1:K25        \+                \+            \+            \+            \+            \+            \+            \+            \-
                                                                                                                                                   
  UCM V586       O8:K22        \+                \-            \-            \-            \-            \-            \-            \+            \+
  KE10443        O3:K6         \+                \-            \-            \-            \-            \-            \-            \+            \+
  KE10464        O3:K6         \+                \-            \-            \-            \-            \-            \-            \+            \+
  AQ4235         O3:K6         \+                \-            \-            \-            \-            \-            \-            \+            \+
  AQ4299         O3:K6         \+                \-            \-            \-            \-            \-            \-            \+            \+
  KE10462        O3:K6         \+                \-            \-            \-            \-            \-            \-            \+            \+
  AQ4037         O3:K6         \+                \-            \-            \-            \-            \-            \-            \+            \+
  KE10461        O3:K6         \+                \-            \-            \-            \-            \-            \-            \+            \+
  KE9967         O3:K6         \+                \-            \-            \-            \-            \-            \-            \+            \+
  KE9984         O3:K6         \+                \-            \-            \-            \-            \-            \-            \+            \+
  U-5474         O3:K6         \+                \-            \-            \-            \-            \-            \-            \+            \+
  ATCC43996      O3:K4         \+                \-            \-            \-            \-            \-            \-            \+            \+
  UCM V553       O3:K53        \+                \-            \-            \-            \-            \-            \-            \+            \+
  UCM V493       O2:K28        \+                \-            \-            \-            \-            \-            \-            \+            \+
  30824          O4:K11        \+                \-            \-            \-            \-            \-            \-            \+            \+
  428/00         N/A           \+                \-            \-            \-            \-            \-            \-            \+            \+
  1324           O4:K8         \+                \-            \-            \-            \-            \-            \-            \+            \+
